Podcast Series: The technology to reopen education
In this series, Barbara looks at what it takes to bring back in-person learning across schools, colleges and universities. In Part 1, Molloy College President Dr. James Lentini joins the podcast alongside Siemens’ Fred James and David Santo to talk about the air purification and technology partnership helping Molloy College expand in-person learning with confidence in 2021.
Subscribe on your favorite podcast platform and follow the series here.
Next Steps: Getting back to the workplace
Being back in the workplace requires confidence. That’s why we’ve developed technology to create safer indoor environments across America, in factories, offices, schools and hospitals. From monitoring occupancy to purifying the air, our technology is making the next step humanly possible. Please watch our “Next Steps” video, at left, and download our brochure, “Siemens USA is Working to Reopen America,” to learn more about how we’re helping keep schools open, manufacturing facilities online, and local governments running.
Siemens experts have innovated to support COVID-19 crisis response teams, manufacturers, and suppliers to keep operations and supply chains up and running. Our software and automation hardware has been applied to help significantly increase manufacturing throughput for critical products, like PPE. These tools can be used in any existing or new manufacturing facility to increase production capacity or switch existing production lines to produce biopharmaceuticals, PPE, or medical devices.
As the national vaccine rollout begins, antibody testing will support the assessment of vaccine effectiveness, which will play a key role in promoting public health. Siemens Healthineers antibody tests are available across the US on the largest installed base of testing equipment, with high throughput, fast turn-around, and substantial capacity for manufacturing approximately 50 million test kits per month in our Massachusetts and Delaware facilities. Antibody testing can also be used to prove the effectiveness of vaccines, enabling public trust in our nation’s efforts to defeat the virus. Tracking antibody levels in months 3, 6 and 9 following vaccination and annually will help to understand how effective the different vaccines are and how long the antibodies last. To further this effort, Siemens Healthineers has collaborated with The Centers for Disease Control and Prevention (CDC) to standardize and determine antibody levels that are necessary for immunity.
The Siemens Foundation, Siemens Healthineers and Siemens employees have donated more than $9.5 million to address the COVID-19 pandemic in the United States, including $2.13 million to 20 community health centers, $500,000 to the National Governors Association’s Reskilling and Recovery Network, and nearly $3 million in funding and COVID-19 testing technologies to Testing for America to support the safe reopening of historically black colleges and universities (HBCUs) across the country. The latter effort enabled Delaware State University to perform 35,000 tests, testing students twice weekly, to provide in-person instruction during the pandemic.
Most recently the Siemens Foundation donated $1.4 million to support COVID-19 vaccination distribution efforts in Black, Latinx, and Indigenous communities.